BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 32343358)

  • 1. Immunoglobulins or convalescent plasma to tackle COVID-19: buying time to save lives - current situation and perspectives.
    Tamburello A; Marando M
    Swiss Med Wkly; 2020 Apr; 150():w20264. PubMed ID: 32343358
    [No Abstract]   [Full Text] [Related]  

  • 2. The resurgence of convalescent plasma therapy.
    The Lancet Haematology
    Lancet Haematol; 2020 May; 7(5):e353. PubMed ID: 32359447
    [No Abstract]   [Full Text] [Related]  

  • 3. Convalescent Plasma: Promise for COVID-19 Pandemic.
    Sheikh S; Baig MA
    J Coll Physicians Surg Pak; 2020 Jun; 30(6):88. PubMed ID: 32723468
    [No Abstract]   [Full Text] [Related]  

  • 4. The convalescent sera option for containing COVID-19.
    Casadevall A; Pirofski LA
    J Clin Invest; 2020 Apr; 130(4):1545-1548. PubMed ID: 32167489
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma Therapies and Parabiosis in the COVID-19 Era.
    Calvani R; Picca A; Landi F; Marzetti E
    J Am Med Dir Assoc; 2020 Jul; 21(7):994-995. PubMed ID: 32674834
    [No Abstract]   [Full Text] [Related]  

  • 6. Passive immunotherapy with convalescent plasma against COVID-19? What about the evidence base and clinical trials?
    Garraud O
    Transfus Apher Sci; 2020 Aug; 59(4):102858. PubMed ID: 32631501
    [No Abstract]   [Full Text] [Related]  

  • 7. Passive antibody therapy in COVID-19.
    Abraham J
    Nat Rev Immunol; 2020 Jul; 20(7):401-403. PubMed ID: 32533109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active Therapy with Passive Immunotherapy May Be Effective in the Fight against COVID-19.
    Morabito CJ; Gangadharan B
    Clin Transl Sci; 2020 Sep; 13(5):835-837. PubMed ID: 32420691
    [No Abstract]   [Full Text] [Related]  

  • 9. Why should we use convalescent plasma for COVID-19?
    Franchini M
    Eur J Intern Med; 2020 Jul; 77():150-151. PubMed ID: 32425365
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of COVID-19: old tricks for new challenges.
    Cunningham AC; Goh HP; Koh D
    Crit Care; 2020 Mar; 24(1):91. PubMed ID: 32178711
    [No Abstract]   [Full Text] [Related]  

  • 11. Convalescent serum lines up as first-choice treatment for coronavirus.
    Sheridan C
    Nat Biotechnol; 2020 Jun; 38(6):655-658. PubMed ID: 32358594
    [No Abstract]   [Full Text] [Related]  

  • 12. Convalescent plasma for covid-19.
    Estcourt LJ; Roberts DJ
    BMJ; 2020 Sep; 370():m3516. PubMed ID: 32933945
    [No Abstract]   [Full Text] [Related]  

  • 13. Convalescent plasma in Covid-19: Possible mechanisms of action.
    Rojas M; Rodríguez Y; Monsalve DM; Acosta-Ampudia Y; Camacho B; Gallo JE; Rojas-Villarraga A; Ramírez-Santana C; Díaz-Coronado JC; Manrique R; Mantilla RD; Shoenfeld Y; Anaya JM
    Autoimmun Rev; 2020 Jul; 19(7):102554. PubMed ID: 32380316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of convalescent plasma for COVID-19 treatment. History and evidence].
    McAllister F; Mantegazza A; Garzón F; Rotbaum V; Remondino G; Vazquez Larsson M; Geffner J; Rabinovich GA; Bover L
    Medicina (B Aires); 2020; 80 Suppl 3():82-86. PubMed ID: 32658853
    [No Abstract]   [Full Text] [Related]  

  • 15. Convalescent plasma as a potential therapy for COVID-19.
    Chen L; Xiong J; Bao L; Shi Y
    Lancet Infect Dis; 2020 Apr; 20(4):398-400. PubMed ID: 32113510
    [No Abstract]   [Full Text] [Related]  

  • 16. Convalescent Plasma and COVID-19.
    Malani AN; Sherbeck JP; Malani PN
    JAMA; 2020 Aug; 324(5):524. PubMed ID: 32530454
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful transfer of anti-SARS-CoV-2 immunity using convalescent plasma in an MM patient with hypogammaglobulinemia and COVID-19.
    Luetkens T; Metcalf R; Planelles V; Zheng Y; Larragoite ET; Spivak ES; Spivak AM; Steinbach M; Blaylock RC; Avila SV; Hankey KG; Martins TB; Slev PR; Mannuel HD; Sajadi M; Rapoport AP; Atanackovic D
    Blood Adv; 2020 Oct; 4(19):4864-4868. PubMed ID: 33031540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Convalescent plasma: A possible treatment protocol for COVID- 19 patients suffering from diabetes or underlying liver diseases.
    Pawar AY; Hiray AP; Sonawane DD; Bhambar RS; Derle DV; Ahire YS
    Diabetes Metab Syndr; 2020; 14(4):665-669. PubMed ID: 32438330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges of Convalescent Plasma Therapy on COVID-19.
    Zhao Q; He Y
    J Clin Virol; 2020 Jun; 127():104358. PubMed ID: 32305026
    [No Abstract]   [Full Text] [Related]  

  • 20. Isopathic Remedy Prepared from Convalescent Plasma as a Therapeutic Option for COVID-19?
    Prajapati S
    Homeopathy; 2020 Aug; 109(3):184-185. PubMed ID: 32645727
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.